
Join to View Full Profile
6420 Rockledge DrBethesda, MD 20817
Phone+1 301-424-6231
Fax+1 301-929-0611
Dr. Goldstein is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Goldstein is an experienced oncologist located in Bethesda, MD, specializing in hematologic oncology. Dr. Goldstein completed a fellowship in hematology and medical oncology and a residency in internal medicine at the University of Connecticut, and an externship in bone marrow transplantation at Yale University. Dr. Goldstein has held various roles, including at Maryland Oncology Hematology and the American Oncology Network. Skilled in hematologic oncology, Dr. Goldstein is knowledgeable in procedures and conditions such as bone marrow biopsy, clotting disorders, anemias, and bleeding disorders. Published works include studies on thymoma and heat-shock proteins in tumorigenesis. Dr. Goldstein participated as a contact or in different roles in several clinical trials. Recognized for contributions to the field, Dr. Goldstein has received honors such as President of the Maryland DC Society of Clinical Oncology and participation in leadership institutes.
Education & Training
Yale UniversityMD, Bone Marrow Transplant externship, 2008 - 2008
University of ConnecticutFellowship, Hematology and Medical Oncology, 2005 - 2008
University of ConnecticutResidency, Internal Medicine, 2002 - 2005
St. George's University School of MedicineClass of 2002
Certifications & Licensure
MD State Medical License 2008 - 2026
DC State Medical License 2020 - 2024
CT State Medical License 2005 - 2022
PA State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- President Maryland DC Society of Clinical Oncology, 2025-2026
- Certified Physician MD Anderson Cancer Center, 2016-2020
- ASH Advocacy Leadership Institute American Society of Hematology, 2019
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 Jun 17
Publications & Presentations
PubMed
- 1 citationsThymoma developing 30 years after mantle radiation for Hodgkin's lymphoma.Mark G. Goldstein, Robert Siegel
Connecticut Medicine. 2009-10-01 - 38 citationsHeat-shock proteins in infection-mediated inflammation-induced tumorigenesisMark G. Goldstein, Zihai Li
Journal of Hematology & Oncology. 2009-01-30
Grant Support
- Howard Hughes Medical Institute Undergraduate Research GrantUniversity of Georgia1996
Professional Memberships
- Fellow
- Member
- Member
- European Society of Medical Oncology (ESMO)Member
- MedChiMember
External Links
- Maryland Oncology Hematologyhttps://marylandoncology.com/personnel/mark-goldstein/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









